{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:13:31Z","timestamp":1773285211986,"version":"3.50.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:00:00Z","timestamp":1555027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s00508-019-1447-z","type":"journal-article","created":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T10:03:08Z","timestamp":1555063388000},"page":"200-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Diabetesmanagement im Krankenhaus (Update 2019)","Hospital diabetes management (Update 2019)"],"prefix":"10.1007","volume":"131","author":[{"given":"Julia K.","family":"Mader","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"Brix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Aberer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Vonbank","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Resl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Pieber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Stechemesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Sourij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,12]]},"reference":[{"issue":"9677","key":"1447_CR1","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","volume":"373","author":"KM Dungan","year":"2009","unstructured":"Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373(9677):1798\u2013807.","journal-title":"Lancet"},{"issue":"2","key":"1447_CR2","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0749-0690(18)30059-4","volume":"15","author":"HK Kamel","year":"1999","unstructured":"Kamel HK, Rodriguez-Saldana J, Flaherty JH, Miller DK. Diabetes mellitus among ethnic seniors: contrasts with diabetes in whites. Clin Geriatr Med. 1999;15(2):265\u201378.","journal-title":"Clin Geriatr Med"},{"issue":"2","key":"1447_CR3","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0749-0690(18)30055-7","volume":"15","author":"JE Morley","year":"1999","unstructured":"Morley JE. An overview of diabetes mellitus in older persons. Clin Geriatr Med. 1999;15(2):211\u201324.","journal-title":"Clin Geriatr Med"},{"issue":"12","key":"1447_CR4","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1097\/CCM.0000000000001353","volume":"43","author":"DL Carpenter","year":"2015","unstructured":"Carpenter DL, Gregg SR, Xu K, Buchman TG, Coopersmith CM. Prevalence and impact of unknown diabetes in the ICU. Crit Care Med. 2015;43(12):e541\u2013e50.","journal-title":"Crit Care Med"},{"issue":"6","key":"1447_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.4158\/EP11042.OR","volume":"17","author":"CM Swanson","year":"2011","unstructured":"Swanson CM, Potter DJ, Kongable GL, Cook CB. Update on inpatient glycemic control in hospitals in the United States. Endocr Pract. 2011;17(6):853\u201361.","journal-title":"Endocr Pract"},{"issue":"4","key":"1447_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2337\/diacare.28.4.810","volume":"28","author":"FA McAlister","year":"2005","unstructured":"McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28(4):810\u20135.","journal-title":"Diabetes Care"},{"issue":"8","key":"1447_CR7","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.2337\/dc10-0304","volume":"33","author":"A Frisch","year":"2010","unstructured":"Frisch A, Chandra P, Smiley D, et\u00a0al. Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care. 2010;33(8):1783\u20138.","journal-title":"Diabetes Care"},{"issue":"12","key":"1447_CR8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.4065\/78.12.1471","volume":"78","author":"JS Krinsley","year":"2003","unstructured":"Krinsley JS. Association between hyperglycemia and increased hospital mortality in a\u00a0heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78(12):1471\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"12","key":"1447_CR9","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1097\/CCM.0b013e3181b083f7","volume":"37","author":"M Falciglia","year":"2009","unstructured":"Falciglia M, Freyberg RW, Almenoff PL, D\u2019Alessio DA, Render ML. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med. 2009;37(12):3001\u20139.","journal-title":"Crit Care Med"},{"issue":"11","key":"1447_CR10","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.2337\/dc08-0672","volume":"31","author":"A Bruno","year":"2008","unstructured":"Bruno A, Gregori D, Caropreso A, Lazzarato F, Petrinco M, Pagano E. Normal glucose values are associated with a\u00a0lower risk of mortality in hospitalized patients. Diabetes Care. 2008;31(11):2209\u201310.","journal-title":"Diabetes Care"},{"issue":"6","key":"1447_CR11","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S2213-8587(17)30097-9","volume":"5","author":"C Bommer","year":"2017","unstructured":"Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20\u201379 years: a\u00a0cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423\u201330.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1447_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1478-7954-8-29","volume":"8","author":"JP Boyle","year":"2010","unstructured":"Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.","journal-title":"Popul Health Metr"},{"issue":"11","key":"1447_CR13","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.2337\/diacare.17.11.1320","volume":"17","author":"S Aro","year":"1994","unstructured":"Aro S, Kangas T, Reunanen A, Salinto M, Koivisto V. Hospital use among diabetic patients and the general population. Diabetes Care. 1994;17(11):1320\u20139.","journal-title":"Diabetes Care"},{"issue":"12","key":"1447_CR14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.2337\/diacare.23.12.1774","volume":"23","author":"PT Donnan","year":"2000","unstructured":"Donnan PT, Leese GP, Morris AD, Diabetes A, Research in Tayside SMMUC. Hospitalizations for people with type 1 and type 2 diabetes compared with the nondiabetic population of Tayside, Scotland: a\u00a0retrospective cohort study of resource use. Diabetes Care. 2000;23(12):1774\u20139.","journal-title":"Diabetes Care"},{"issue":"3","key":"1447_CR15","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","volume":"87","author":"GE Umpierrez","year":"2002","unstructured":"Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J\u00a0Clin Endocrinol Metab. 2002;87(3):978\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1447_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jdiacomp.2018.04.007","volume":"32","author":"RG McCoy","year":"2018","unstructured":"McCoy RG, Herrin J, Lipska KJ, Shah ND. Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes. J\u00a0Diabetes Complicat. 2018;32(7):693\u2013701.","journal-title":"J Diabetes Complicat"},{"issue":"10","key":"1447_CR17","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s11606-017-4095-x","volume":"32","author":"RG McCoy","year":"2017","unstructured":"McCoy RG, Lipska KJ, Herrin J, Jeffery MM, Krumholz HM, Shah ND. Hospital readmissions among commercially insured and medicare advantage beneficiaries with diabetes and the impact of severe hypoglycemic and hyperglycemic events. J\u00a0Gen Intern Med. 2017;32(10):1097\u2013105.","journal-title":"J Gen Intern Med"},{"issue":"5","key":"1447_CR18","doi-asserted-by":"publisher","first-page":"e63675","DOI":"10.1371\/journal.pone.0063675","volume":"8","author":"F Lombardo","year":"2013","unstructured":"Lombardo F, Maggini M, Gruden G, Bruno G. Temporal trend in hospitalizations for acute diabetic complications: a\u00a0nationwide study, Italy, 2001\u20132010. PLoS ONE. 2013;8(5):e63675.","journal-title":"PLoS ONE"},{"issue":"6","key":"1447_CR19","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00134-015-3757-6","volume":"41","author":"Australian N\u2011SSIft","year":"2015","unstructured":"Australian N\u2011SSIft, New Zealand Intensive Care Society Clinical Trials G, Canadian Critical Care Trials G, Canadian Critical Care Trials G. Intensive versus conventional glucose control in critically ill patients with traumatic brain injury: long-term follow-up of a\u00a0subgroup of patients from the NICE-SUGAR study. Intensive Care Med. 2015;41(6):1037\u201347.","journal-title":"Intensive Care Med"},{"issue":"Suppl 1","key":"1447_CR20","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.2337\/dc18-S014","volume":"41","author":"American Diabetes A","year":"2018","unstructured":"American Diabetes A. 14. Diabetes care in the hospital: standards of medical care in diabetes-2018. Diabetes Care. 2018;41(Suppl 1):S144\u2013S51.","journal-title":"Diabetes Care"},{"issue":"1","key":"1447_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.2337\/dc16-2215","volume":"40","author":"International Hypoglycaemia Study G","year":"2017","unstructured":"International Hypoglycaemia Study G. Glucose concentrations of less than 3.0\u202fmmol\/L (54\u202fmg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association For The Study of Diabetes. Diabetes Care. 2017;40(1):155\u20137.","journal-title":"Diabetes Care"},{"issue":"6","key":"1447_CR22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2337\/dc09-9029","volume":"32","author":"ES Moghissi","year":"2009","unstructured":"Moghissi ES, Korytkowski MT, DiNardo M, et\u00a0al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119\u201331.","journal-title":"Diabetes Care"},{"issue":"2","key":"1447_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1055\/s-0043-112653","volume":"126","author":"J Kufeldt","year":"2018","unstructured":"Kufeldt J, Kovarova M, Adolph M, et al. Prevalence and distribution of diabetes mellitus in a\u00a0maximum care hospital: urgent need for HbA1c-screening. Exp Clin Endocrinol Diabetes. 2018;126(2):123\u20139.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"1447_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1210\/jc.2011-2098","volume":"97","author":"GE Umpierrez","year":"2012","unstructured":"Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J\u00a0Clin Endocrinol Metab. 2012;97(1):16\u201338.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1447_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1573399054022794","volume":"1","author":"AB King","year":"2005","unstructured":"King AB, Armstrong DU. Basal bolus dosing: a\u00a0clinical experience. Curr Diabetes Rev. 2005;1(2):215\u201320.","journal-title":"Curr Diabetes Rev"},{"issue":"2","key":"1447_CR26","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1210\/jc.2008-1441","volume":"94","author":"GE Umpierrez","year":"2009","unstructured":"Umpierrez GE, Hor T, Smiley D, et\u00a0al. Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J\u00a0Clin Endocrinol Metab. 2009;94(2):564\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1447_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2337\/diacare.27.2.553","volume":"27","author":"S Clement","year":"2004","unstructured":"Clement S, Braithwaite SS, Magee MF, et\u00a0al. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27(2):553\u201391.","journal-title":"Diabetes Care"},{"issue":"9","key":"1447_CR28","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2337\/dc07-0295","volume":"30","author":"GE Umpierrez","year":"2007","unstructured":"Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181\u20136.","journal-title":"Diabetes Care"},{"issue":"8","key":"1447_CR29","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.2337\/dc10-2434","volume":"34","author":"DJ Rubin","year":"2011","unstructured":"Rubin DJ, Rybin D, Doros G, McDonnell ME. Weight-based, insulin dose-related hypoglycemia in hospitalized patients with diabetes. Diabetes Care. 2011;34(8):1723\u20138.","journal-title":"Diabetes Care"},{"key":"1447_CR30","doi-asserted-by":"publisher","DOI":"10.2337\/db18-2280-PUB","author":"RE Rainer","year":"2018","unstructured":"Rainer RE, Elsayed H, Aberer F, Beck P, Pieber TR, Donsa K, Plank J, Mader JK. Diabetes management in hospitalized patients with type 2 diabetes (T2D) during fasting periods. Diabetes. 2018; \n                    https:\/\/doi.org\/10.2337\/db18-2280-PUB\n                    \n                  .","journal-title":"Diabetes"},{"issue":"6","key":"1447_CR31","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/dme.12756","volume":"32","author":"S George","year":"2015","unstructured":"George S, Dale J, Stanisstreet D, Joint British Diabetes Societies for Inpatient C, Group JMVW. A guideline for the use of variable rate intravenous insulin infusion in medical inpatients. Diabet Med. 2015;32(6):706\u201313.","journal-title":"Diabet Med"},{"issue":"3","key":"1447_CR32","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/dia.2006.0015","volume":"9","author":"R Juneja","year":"2007","unstructured":"Juneja R, Roudebush C, Kumar N, et\u00a0al. Utilization of a\u00a0computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007;9(3):232\u201340.","journal-title":"Diabetes Technol Ther"},{"key":"1447_CR33","volume-title":"Diabetes facts and guidelines","author":"SE Inzucchi","year":"2011","unstructured":"Inzucchi SE. Diabetes facts and guidelines. New Haven: Yale Diabetes Center; 2011."},{"issue":"7","key":"1447_CR34","first-page":"986","volume":"40","author":"American Diabetes A","year":"2017","unstructured":"American Diabetes A. Erratum. Diabetes care in the hospital. Sec. 14. In standards of medical care in diabetes-2017. Diabetes Care 2017;40(Suppl. 1);S120\u2013S127. Diabetes Care. 2017;40(7):986.","journal-title":"Diabetes Care"},{"issue":"5","key":"1447_CR35","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1067\/mtc.2003.181","volume":"125","author":"AP Furnary","year":"2003","unstructured":"Furnary AP, Gao G, Grunkemeier GL, et\u00a0al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J\u00a0Thorac Cardiovasc Surg. 2003;125(5):1007\u201321.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"1447_CR36","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0003-4975(99)00014-4","volume":"67","author":"AP Furnary","year":"1999","unstructured":"Furnary AP, Zerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg. 1999;67(2):352\u201360. discussion 360\u2013352.","journal-title":"Ann Thorac Surg"},{"issue":"19","key":"1447_CR37","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1056\/NEJMoa011300","volume":"345","author":"G Berghe van den","year":"2001","unstructured":"van den Berghe G, Wouters P, Weekers F, et\u00a0al. Intensive insulin therapy in critically ill patients. N\u00a0Engl J Med. 2001;345(19):1359\u201367.","journal-title":"N Engl J Med"},{"issue":"2","key":"1447_CR38","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2337\/diacare.27.2.461","volume":"27","author":"PA Goldberg","year":"2004","unstructured":"Goldberg PA, Siegel MD, Sherwin RS, et\u00a0al. Implementation of a\u00a0safe and effective insulin infusion protocol in a\u00a0medical intensive care unit. Diabetes Care. 2004;27(2):461\u20137.","journal-title":"Diabetes Care"},{"issue":"10","key":"1447_CR39","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11892-017-0919-7","volume":"17","author":"CE Mendez","year":"2017","unstructured":"Mendez CE, Umpierrez GE. Management of type 1 diabetes in the hospital setting. Curr Diab Rep. 2017;17(10):98.","journal-title":"Curr Diab Rep"},{"issue":"4","key":"1447_CR40","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/0003-4819-146-4-200702200-00002","volume":"146","author":"GY Gandhi","year":"2007","unstructured":"Gandhi GY, Nuttall GA, Abel MD, et\u00a0al. Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a\u00a0randomized trial. Ann Intern Med. 2007;146(4):233\u201343.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1447_CR41","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/EJA.0b013e3283495ba1","volume":"28","author":"I Smith","year":"2011","unstructured":"Smith I, Kranke P, Murat I, et\u00a0al. Perioperative fasting in adults and children: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2011;28(8):556\u201369.","journal-title":"Eur J Anaesthesiol"},{"issue":"18","key":"1447_CR42","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1056\/NEJMcp060094","volume":"355","author":"SE Inzucchi","year":"2006","unstructured":"Inzucchi SE. Clinical practice. Management of hyperglycemia in the hospital setting. N\u00a0Engl J Med. 2006;355(18):1903\u201311.","journal-title":"N Engl J Med"},{"issue":"6","key":"1447_CR43","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1210\/jc.2003-030347","volume":"88","author":"DL Trence","year":"2003","unstructured":"Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J\u00a0Clin Endocrinol Metab. 2003;88(6):2430\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1447_CR44","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2337\/dc16-0989","volume":"40","author":"GE Umpierrez","year":"2017","unstructured":"Umpierrez GE, Pasquel FJ. Management of inpatient hyperglycemia and diabetes in older adults. Diabetes Care. 2017;40(4):509\u201317.","journal-title":"Diabetes Care"},{"issue":"12","key":"1447_CR45","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","volume":"21","author":"F Stacul","year":"2011","unstructured":"Stacul F, van der Molen AJ, Reimer P, et\u00a0al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21(12):2527\u201341.","journal-title":"Eur Radiol"},{"key":"1447_CR46","volume-title":"Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus","author":"Deutsche Diabetesgesellschaft","year":"2017","unstructured":"Deutsche Diabetesgesellschaft. Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus. 2017."},{"issue":"6","key":"1447_CR47","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.kint.2016.09.010","volume":"90","author":"V Perkovic","year":"2016","unstructured":"Perkovic V, Agarwal R, Fioretto P, et\u00a0al. Management of patients with diabetes and CKD: conclusions from a\u00a0\u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference. Kidney Int. 2016;90(6):1175\u201383.","journal-title":"Kidney Int"},{"issue":"11","key":"1447_CR48","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1111\/dom.12974","volume":"19","author":"JD Lalau","year":"2017","unstructured":"Lalau JD, Kajbaf F, Protti A, Christensen MM, De Broe ME, Wiernsperger N. Metformin-associated lactic acidosis (MALA): moving towards a\u00a0new paradigm. Diabetes Obes Metab. 2017;19(11):1502\u201312.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"1447_CR49","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/ajcp\/80.4.484","volume":"80","author":"D Luft","year":"1983","unstructured":"Luft D, Deichsel G, Schmulling RM, Stein W, Eggstein M. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol. 1983;80(4):484\u20139.","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"1447_CR50","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/j.1875-9114.2011.01088.x","volume":"32","author":"CM Deusenberry","year":"2012","unstructured":"Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy. 2012;32(7):613\u20137.","journal-title":"Pharmacotherapy"},{"issue":"2","key":"1447_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S2213-8587(16)30402-8","volume":"5","author":"FJ Pasquel","year":"2017","unstructured":"Pasquel FJ, Gianchandani R, Rubin DJ, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a\u00a0multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017;5(2):125\u201333.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"1447_CR52","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.2337\/dc13-0277","volume":"36","author":"GE Umpierrez","year":"2013","unstructured":"Umpierrez GE, Gianchandani R, Smiley D, et\u00a0al. Safety and efficacy of sitagliptin therapy for the inpatient management of general medicine and surgery patients with type 2 diabetes: a\u00a0pilot, randomized, controlled study. Diabetes Care. 2013;36(11):3430\u20135.","journal-title":"Diabetes Care"},{"key":"1447_CR53","volume-title":"FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin 2016","author":"US Food and Drug Association","year":"2016","unstructured":"US Food and Drug Association. FDA adds warnings about heart failure risk to labels of type 2 diabetes medicines containing saxagliptin and alogliptin 2016. 2016. \n                    http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm486096.htm\n                    \n                  . Zugegriffen: 3.10.2018."},{"issue":"19","key":"1447_CR54","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et\u00a0al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N\u00a0Engl J Med. 2016;375(19):1834\u201344.","journal-title":"N Engl J Med"},{"issue":"4","key":"1447_CR55","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N\u00a0Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"22","key":"1447_CR56","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et\u00a0al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N\u00a0Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"4","key":"1447_CR57","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","volume":"12","author":"G Umpierrez","year":"2016","unstructured":"Umpierrez G, Korytkowski M. Diabetic emergencies \u2013 ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia. Nat Rev Endocrinol. 2016;12(4):222\u2013232.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"1447_CR58","first-page":"62","volume":"72","author":"DH Raalte van","year":"2014","unstructured":"van Raalte DH, Diamant M. Steroid diabetes: from mechanism to treatment? Neth J Med. 2014;72(2):62\u201372.","journal-title":"Neth J Med"},{"issue":"8","key":"1447_CR59","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.4239\/wjd.v6.i8.1073","volume":"6","author":"HE Tamez-Perez","year":"2015","unstructured":"Tamez-Perez HE, Quintanilla-Flores DL, Rodriguez-Gutierrez R, Gonzalez-Gonzalez JG, Tamez-Pena AL. Steroid hyperglycemia: prevalence, early detection and therapeutic recommendations: a narrative review. World J Diabetes. 2015;6(8):1073\u201381.","journal-title":"World J Diabetes"},{"issue":"2","key":"1447_CR60","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.diabres.2015.02.010","volume":"108","author":"T Katsuyama","year":"2015","unstructured":"Katsuyama T, Sada KE, Namba S, et al. Risk factors for the development of glucocorticoid-induced diabetes mellitus. Diabetes Res Clin Pract. 2015;108(2):273\u20139.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"1447_CR61","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.bbmt.2017.03.010","volume":"23","author":"MN Stauber","year":"2017","unstructured":"Stauber MN, Aberer F, Oulhaj A, et al. Early hyperglycemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease. Biol Blood Marrow Transplant. 2017;23(7):1186\u201392.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"1447_CR62","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/sj.ki.5000116","volume":"69","author":"J Hjelmesaeth","year":"2006","unstructured":"Hjelmesaeth J, Hartmann A, Leivestad T, et al. The impact of early-diagnosed new-onset post-transplantation diabetes mellitus on survival and major cardiac events. Kidney Int. 2006;69(3):588\u201395.","journal-title":"Kidney Int"},{"issue":"5","key":"1447_CR63","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4158\/EP08331.RAR","volume":"15","author":"JN Clore","year":"2009","unstructured":"Clore JN, Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract. 2009;15(5):469\u201374.","journal-title":"Endocr Pract"},{"issue":"2","key":"1447_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4158\/EP.13.2.117","volume":"13","author":"CB Cook","year":"2007","unstructured":"Cook CB, McNaughton DA, Braddy CM, et\u00a0al. Management of inpatient hyperglycemia: assessing perceptions and barriers to care among resident physicians. Endocr Pract. 2007;13(2):117\u201324.","journal-title":"Endocr Pract"},{"issue":"5","key":"1447_CR65","doi-asserted-by":"publisher","first-page":"415","DOI":"10.4158\/EP09063.ORR","volume":"15","author":"ML Noschese","year":"2009","unstructured":"Noschese ML, DiNardo MM, Donihi AC, et\u00a0al. Patient outcomes after implementation of a\u00a0protocol for inpatient insulin pump therapy. Endocr Pract. 2009;15(5):415\u201324.","journal-title":"Endocr Pract"},{"issue":"2","key":"1447_CR66","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jcjd.2014.01.011","volume":"38","author":"RL Houlden","year":"2014","unstructured":"Houlden RL, Moore S. In-hospital management of adults using insulin pump therapy. Can J Diabetes. 2014;38(2):126\u201333.","journal-title":"Can J Diabetes"},{"issue":"3","key":"1447_CR67","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1177\/1932296814522809","volume":"8","author":"S Kannan","year":"2014","unstructured":"Kannan S, Satra A, Calogeras E, Lock P, Lansang MC. Insulin pump patient characteristics and glucose control in the hospitalized setting. J\u00a0Diabetes Sci Technol. 2014;8(3):473\u20138.","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"1447_CR68","doi-asserted-by":"publisher","first-page":"746","DOI":"10.4158\/EP.16.5.746","volume":"16","author":"G Grunberger","year":"2010","unstructured":"Grunberger G, Bailey TS, Cohen AJ, et\u00a0al. Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management. Endocr Pract. 2010;16(5):746\u201362.","journal-title":"Endocr Pract"},{"issue":"8","key":"1447_CR69","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.2337\/dci18-0002","volume":"41","author":"GE Umpierrez","year":"2018","unstructured":"Umpierrez GE, Klonoff DC. Diabetes technology update: use of insulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579\u201389.","journal-title":"Diabetes Care"},{"issue":"10","key":"1447_CR70","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1210\/jc.2010-2756","volume":"96","author":"DC Klonoff","year":"2011","unstructured":"Klonoff DC, Buckingham B, Christiansen JS, et\u00a0al. Continuous glucose monitoring: an Endocrine Society clinical practice guideline. J\u00a0Clin Endocrinol Metab. 2011;96(10):2968\u201379.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1447_CR71","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/jhm.2109","volume":"8","author":"MC Lansang","year":"2013","unstructured":"Lansang MC, Modic MB, Sauvey R, et\u00a0al. Approach to the adult hospitalized patient on an insulin pump. J\u00a0Hosp Med. 2013;8(12):721\u20137.","journal-title":"J Hosp Med"},{"issue":"9","key":"1447_CR72","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/dia.2014.0343","volume":"17","author":"L Schaupp","year":"2015","unstructured":"Schaupp L, Donsa K, Neubauer KM, et al. Taking a\u00a0closer look\u2014continuous glucose monitoring in non-critically ill hospitalized patients with type 2 diabetes mellitus under basal-bolus insulin therapy. Diabetes Technol Ther. 2015;17(9):611\u20138.","journal-title":"Diabetes Technol Ther"},{"key":"1447_CR73","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1805233","author":"L Bally","year":"2018","unstructured":"Bally L, Thabit H, Hartnell S, et al. Closed-loop insulin delivery for glycemic control in noncritical care. N\u00a0Engl J Med. 2018; \n                    https:\/\/doi.org\/10.1056\/nejmoa1805233\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"2","key":"1447_CR74","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1177\/193229681300700217","volume":"7","author":"KM Neubauer","year":"2013","unstructured":"Neubauer KM, Schaupp L, Plank J, et\u00a0al. Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a\u00a0hospital setting. J\u00a0Diabetes Sci Technol. 2013;7(2):402\u20139.","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"1447_CR75","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1177\/1932296816676501","volume":"11","author":"S Spat","year":"2017","unstructured":"Spat S, Donsa K, Beck P, et\u00a0al. A mobile computerized decision support system to prevent hypoglycemia in hospitalized patients with type 2 diabetes mellitus. J\u00a0Diabetes Sci Technol. 2017;11(1):20\u20138.","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"1447_CR76","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1089\/dia.2015.0027","volume":"17","author":"KM Neubauer","year":"2015","unstructured":"Neubauer KM, Mader JK, Holl B, et\u00a0al. Standardized glycemic management with a\u00a0computerized workflow and decision support system for hospitalized patients with type 2 diabetes on different wards. Diabetes Technol Ther. 2015;17(10):685\u201392.","journal-title":"Diabetes Technol Ther"},{"key":"1447_CR77","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijmedinf.2016.03.007","volume":"90","author":"K Donsa","year":"2016","unstructured":"Donsa K, Beck P, Holl B, et al. Impact of errors in paper-based and computerized diabetes management with decision support for hospitalized patients with type 2 diabetes. A post-hoc analysis of a\u00a0before and after study. Int J Med Inform. 2016;90:58\u201367.","journal-title":"Int J Med Inform"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-1447-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-019-1447-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-019-1447-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T23:21:36Z","timestamp":1586560896000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-019-1447-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,12]]},"references-count":77,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["1447"],"URL":"https:\/\/doi.org\/10.1007\/s00508-019-1447-z","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,12]]},"assertion":[{"value":"12 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.K.\u00a0Mader: Honorare von Novo Nordisk, Sanofi-Aventis, Nintamed, Eli Lilly, Takeda, Merck Sharp & Dohme, AstraZeneca, Boehringer-Ingelheim, Medtronic Minimed, Roche Diabetes Care. Forschungsgelder von A.\u00a0Menarini Diagnostics, B.\u00a0Braun, Metronom Health, Novo Nordisk, Roche Diabetes Care, Sanofi-Aventis. J.\u00a0Brix: Honorare von AstraZeneca, Bayer, Boehringer-Ingelheim, Eli Lilly, MSD, Novartis, Novo Nordisk. F.\u00a0Aberer: Speaker-Honorare von Boehringer-Ingelheim, AstraZeneca; Reisehonorare von Sanofi-Aventis, MSD, Takeda. A.\u00a0Vonbank: Honorare von Amgen, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Bayer, MSD, AstraZeneca, Roche, Sanofi-Aventis. M.\u00a0Resl: Honorare von Novo Nordisk, Sanofi-Aventis, Dexcom, Boehringer-Ingelheim. T.R.\u00a0Pieber: Direktor des Institutes f\u00fcr Biomedizin und Gesundheitswissenschaften (HEALTH) von JOANNEUM RESEARCH. Wissenschaftlicher Vorstand von CBmed (Zentrum f\u00fcr Biomarkerforschung). Vortragshonorare von der Firma Novo Nordisk. Mitglied von Advisory Boards von den Firmen Arecor, Novo Nordisk, Sanofi, AstraZeneca, Adocia. L.\u00a0Stechemesser: Forschungsunterst\u00fctzungen und\/oder Honorare von Abbott, AstraZeneca, Boehringer-Ingelheim, Eli Lilly, Medtronic, MSD, Novartis, Novo Nordisk, Roche, Sanofi-Aventis. H.\u00a0Sourij hat von folgenden Unternehmen, die auch f\u00f6rdernde Mitglieder der \u00d6DG sind, Forschungsunterst\u00fctzungen und\/oder Honorare erhalten: Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, Sanofi-Aventis, Takeda.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}